Facilitated subcutaneous immunoglobulin (fSCIg) therapy – practical considerations

There is an increasing range of therapeutic options for primary antibody-deficient patients who require replacement immunoglobulin. These include intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), rapid push SCIg and most recently recombinant human hyaluronidase-facilitated SCIg...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Exp Immunol
Main Authors: Ponsford, M, Carne, E, Kingdon, C, Joyce, C, Price, C, Williams, C, El-Shanawany, T, Williams, P, Jolles, S
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Ltd 2015
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636892/
https://ncbi.nlm.nih.gov/pubmed/26288095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12694
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍